Cervical cancer in India and HPV vaccination
- PMID: 22754202
- PMCID: PMC3385284
- DOI: 10.4103/0971-5851.96961
Cervical cancer in India and HPV vaccination
Abstract
Cervical cancer, mainly caused by Human Papillomavirus infection, is the leading cancer in Indian women and the second most common cancer in women worldwide. Though there are several methods of prevention of cervical cancer, prevention by vaccination is emerging as the most effective option, with the availability of two vaccines. Several studies have been published examining the vaccine's efficacy, immunogenicity and safety. Questions and controversy remain regarding mandatory vaccination, need for booster doses and cost-effectiveness, particularly in the Indian context.
Keywords: Cancer; cervix; human papillomavirus; vaccine.
Conflict of interest statement
References
-
- Schiffman M, Castle PE, Jeronim J, Rodrigue AC, Wacholde S. Human papillomavirus and cervical cancer. Lancet. 2007;370:890–907. - PubMed
-
- Sankaranarayanan R, Ferlay J. Worldwide burden of gynecological cancer: The size of the problem. Best Pract Res Clin Obstet Gynaecol. 2006;20:207–25. - PubMed
-
- Singh N. HPV and Cervical cancer - prospects for prevention through vaccination. Indian J Med Paediatr Oncol. 2005;26:20–3.
-
- WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Summary report on HPV and cervical cancer statistics in India 2007. [Last Assessed on 2008 May 1]. Available from: http://www.who.int/hpvcentre .
-
- Howley PM, Lowy DR. Papillomaviruses and their replication, chapter 65. In: Knipe DM, Howley PM, editors. Field's Virology. 4th ed. Vol. 2. Philadelphia: Lippincott Williams and Wilkins; 2001. pp. 2197–229.
LinkOut - more resources
Full Text Sources
